Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
49 | 2 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 30279 |
208 | 1 | IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER | 3955 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | IAVI NEUTRALIZING ANTIBODY | address | 720327 | 3% | 84% | 108 |
2 | DUKE HUMAN VACCINE | address | 566445 | 4% | 44% | 162 |
3 | HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER | address | 520471 | 2% | 78% | 84 |
4 | BROADLY NEUTRALIZING ANTIBODIES | authKW | 470869 | 2% | 73% | 81 |
5 | INT AIDS VACCINE INITIAT NEUTRALIZING ANTIBODY CT | address | 351870 | 1% | 79% | 56 |
6 | VACCINE | address | 342853 | 8% | 13% | 332 |
7 | NEUTRALIZING ANTIBODIES | authKW | 335995 | 6% | 17% | 244 |
8 | IMMUNOL MICROBIAL SCI | address | 242721 | 5% | 17% | 181 |
9 | VIROLOGY | WoSSC | 195419 | 53% | 1% | 2095 |
10 | GP120 | authKW | 188907 | 3% | 18% | 132 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Virology | 195419 | 53% | 1% | 2095 |
2 | Immunology | 26998 | 40% | 0% | 1568 |
3 | Infectious Diseases | 17435 | 20% | 0% | 798 |
4 | Medicine, Research & Experimental | 1572 | 9% | 0% | 339 |
5 | Microbiology | 732 | 7% | 0% | 280 |
6 | Biochemistry & Molecular Biology | 677 | 15% | 0% | 599 |
7 | Parasitiology | 363 | 2% | 0% | 86 |
8 | Cell Biology | 191 | 6% | 0% | 226 |
9 | Biochemical Research Methods | 142 | 3% | 0% | 118 |
10 | Biophysics | 140 | 3% | 0% | 130 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | IAVI NEUTRALIZING ANTIBODY | 720327 | 3% | 84% | 108 |
2 | DUKE HUMAN VACCINE | 566445 | 4% | 44% | 162 |
3 | HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER | 520471 | 2% | 78% | 84 |
4 | INT AIDS VACCINE INITIAT NEUTRALIZING ANTIBODY CT | 351870 | 1% | 79% | 56 |
5 | VACCINE | 342853 | 8% | 13% | 332 |
6 | IMMUNOL MICROBIAL SCI | 242721 | 5% | 17% | 181 |
7 | VIROL VACCINE | 160162 | 2% | 33% | 61 |
8 | NEUTRALIZING ANTIBODY | 145319 | 1% | 79% | 23 |
9 | ABORAT AIDS VACCINE DISCOVERY | 135856 | 0% | 95% | 18 |
10 | SCRIPPS HIV AIDS VACCINE IMMUNOL IMMUNOGEN | 130726 | 0% | 86% | 19 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 129421 | 8% | 5% | 298 |
2 | JOURNAL OF VIROLOGY | 114928 | 19% | 2% | 760 |
3 | CURRENT OPINION IN HIV AND AIDS | 29208 | 1% | 6% | 57 |
4 | CURRENT HIV RESEARCH | 18148 | 1% | 5% | 44 |
5 | VIROLOGY | 15428 | 5% | 1% | 192 |
6 | RETROVIROLOGY | 14711 | 1% | 4% | 48 |
7 | AIDS | 14230 | 3% | 1% | 126 |
8 | VACCINE | 10257 | 4% | 1% | 156 |
9 | PLOS PATHOGENS | 6469 | 2% | 1% | 70 |
10 | JOURNAL OF INFECTIOUS DISEASES | 4365 | 3% | 1% | 101 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BROADLY NEUTRALIZING ANTIBODIES | 470869 | 2% | 73% | 81 | Search BROADLY+NEUTRALIZING+ANTIBODIES | Search BROADLY+NEUTRALIZING+ANTIBODIES |
2 | NEUTRALIZING ANTIBODIES | 335995 | 6% | 17% | 244 | Search NEUTRALIZING+ANTIBODIES | Search NEUTRALIZING+ANTIBODIES |
3 | GP120 | 188907 | 3% | 18% | 132 | Search GP120 | Search GP120 |
4 | V3 LOOP | 184815 | 1% | 39% | 59 | Search V3+LOOP | Search V3+LOOP |
5 | HIV 1 | 184040 | 11% | 5% | 447 | Search HIV+1 | Search HIV+1 |
6 | GP41 | 128932 | 2% | 22% | 73 | Search GP41 | Search GP41 |
7 | ENVELOPE GLYCOPROTEIN | 127926 | 2% | 26% | 63 | Search ENVELOPE+GLYCOPROTEIN | Search ENVELOPE+GLYCOPROTEIN |
8 | HIV VACCINE | 124890 | 2% | 21% | 74 | Search HIV+VACCINE | Search HIV+VACCINE |
9 | HIV 1 VACCINE | 122878 | 1% | 43% | 36 | Search HIV+1+VACCINE | Search HIV+1+VACCINE |
10 | MPER | 117102 | 1% | 70% | 21 | Search MPER | Search MPER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |